U.S. markets closed
  • S&P 500

    3,978.73
    +37.25 (+0.95%)
     
  • Dow 30

    32,120.28
    +191.66 (+0.60%)
     
  • Nasdaq

    11,434.74
    +170.29 (+1.51%)
     
  • Russell 2000

    1,799.16
    +34.34 (+1.95%)
     
  • Crude Oil

    110.74
    +0.41 (+0.37%)
     
  • Gold

    1,852.00
    +5.70 (+0.31%)
     
  • Silver

    21.98
    +0.11 (+0.50%)
     
  • EUR/USD

    1.0685
    -0.0053 (-0.49%)
     
  • 10-Yr Bond

    2.7490
    -0.0110 (-0.40%)
     
  • GBP/USD

    1.2579
    +0.0047 (+0.37%)
     
  • USD/JPY

    127.2410
    +0.4120 (+0.32%)
     
  • BTC-USD

    29,810.88
    +214.97 (+0.73%)
     
  • CMC Crypto 200

    659.93
    -11.08 (-1.65%)
     
  • FTSE 100

    7,522.75
    +38.40 (+0.51%)
     
  • Nikkei 225

    26,677.80
    -70.34 (-0.26%)
     

Why Amarin Stock Is Tumbling This Week

·2 min read
Why Amarin Stock Is Tumbling This Week
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Amarin (NASDAQ: AMRN), a small-cap cardiovascular care company, saw its shares dip by as much as 15% during the first four days of trading this week, according to data provided by S&P Global Market Intelligence. The good news is that Amarin's stock didn't fall in response to a company-specific event. Underscoring this point, the bellwether SPDR S&P Biotech ETF has dropped by an unsightly 14.9% over the prior four trading sessions.